| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2000;31:425.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Department of Epidemiology and Biostatistics (F.-E. de L., J.C. de G., J.C.M.W., A.H., M.M.B.B.) and the Department of Radiology, Daniel den Hoed Cancer Clinic (M.O.), Erasmus University Medical School, Rotterdam, and the Department of Neurology, University Medical Center Utrecht (F.-E. de L., J.v.G.), Netherlands.
Correspondence to Dr Monique Breteler, Department of Epidemiology and Biostatistics, Erasmus University Medical School, PO Box 1738, 3000 DR Rotterdam, Netherlands. E-mail breteler{at}epib.fgg.eur.nl
| Abstract |
|---|
|
|
|---|
MethodsWe randomly sampled subjects between 60 and 90 years old from 2 population-based follow-up studies in which subjects had their baseline examinations in 1975 to 1978 (midlife) and in 1990 to 1993 (late life). In 1995 to 1996, subjects underwent 1.5-T MRI scanning; white matter lesions were rated in the deep subcortical and periventricular regions separately. Aortic atherosclerosis was assessed on abdominal radiographs that were obtained from 276 subjects in midlife and 531 subjects in late life.
ResultsThe presence of aortic atherosclerosis
during midlife was significantly associated with the presence of
periventricular white matter lesions
20 years later
(adjusted relative risk, 2.4; 95% CI, 1.2 to 5.0); the relative risks
increased linearly with the severity of aortic
atherosclerosis. No association was found between
midlife aortic atherosclerosis and subcortical white
matter lesions (adjusted relative risk, 1.1; 95% CI, 0.5 to 2.3) or
between late-life aortic atherosclerosis and white
matter lesions.
ConclusionsThe pathogenetic process that leads to cerebral periventricular white matter lesions starts already in or before midlife. The critical period for intervention directed at prevention of white matter lesions and its cognitive consequences may be long before these lesions become clinically detectable.
Key Words: cerebrovascular disorders atherosclerosis leukoaraiosis magnetic resonance imaging white matter
| Introduction |
|---|
|
|
|---|
We studied the association between the presence and severity of aortic atherosclerosis assessed during midlife or late life and the later presence of cerebral white matter lesions in the Rotterdam Scan Study.
| Subjects and Methods |
|---|
|
|
|---|
55 years old that
focuses on determinants of neurological,
cardiovascular, locomotor, and ophthalmological
disorders in the elderly. Both studies have been described in detail
elsewhere.18 19 For the Rotterdam Scan Study, subjects were invited by letter and subsequently contacted by telephone. Upon a subjects agreement to participate in the study, a list of contraindications was reviewed to assess eligibility (dementia; blindness; or presence of MRI contraindications, including prosthetic valves, pacemaker, cerebral aneurysm clips, intraocular metal fragments, cochlear implants, and claustrophobia). Of 1904 invited subjects, 1717 were eligible. Complete information, including a cerebral MRI scan, was obtained from 1077 persons (response, 63%): 563 from the Rotterdam Study (response, 68%) and 514 from the Zoetermeer Study (response, 58%). Each participant signed an informed consent form. The study was approved by the medical ethics committee of Erasmus University.
Measurement of Aortic Atherosclerosis
Abdominal radiographs were taken in subjects
45 years
old at the time of baseline data collection of the Zoetermeer Study. In
305 of the 401 subjects in our study who were >45 years old at the
time of baseline data collection, a lateral abdominal radiograph had
been obtained (76%, comparable to the initial response of 82% for
abdominal radiographs back in 1975). During the follow-up study (1995
to 1996), 276 of these radiographs could be retrieved. Abdominal
radiographs were also obtained during the baseline examination of the
Rotterdam Study. An abdominal radiograph had been obtained in 531 of
our participants (response, 94%). Aortic
atherosclerosis was considered present if calcified
deposits were visible as linear densities in an area parallel and
anterior to the lumbar spine. The severity of
atherosclerosis was rated as mild when deposits were
between 0 and 1 cm and as moderate to severe when deposits were
1
cm.
Measurement of Other Baseline Covariates
All measurements were done in a similar way at baseline and
follow-up in both subpopulations of the Rotterdam Scan Study. Height
and weight were measured with the subject without shoes and in light
clothing. The body mass index was calculated as weight divided by
height squared. Blood pressure was measured 2 times on the right arm by
means of a random-zero sphygmomanometer with the subject in the sitting
position. The average of these measurements was used. Hypertension was
defined as a systolic blood pressure
160 mm Hg and/or a
diastolic blood pressure
95 mm Hg and/or the
self-reported use of blood pressurelowering medication. Information
on smoking was obtained through a standardized questionnaire, which was
checked by a physician during the interview. Diabetes mellitus was
considered present if the participant was taking oral antidiabetics
or insulin (both subpopulations) or if the random or postload
glucose level was >11.1 mmol/L (subjects originating from the
Rotterdam Study).20 Serum total cholesterol
was measured by an automated enzymatic method.21
MRI Scanning Protocol
An axial T1-, T2-, and proton density (PD)-weighted cerebral MRI
scan was made on a 1.5-T MRI scan in all participants. Subjects
recruited from the Zoetermeer Study were scanned with a 1.5-T MR
Gyroscan (Philips), and participants from the Rotterdam Study were
scanned with a 1.5-T MR Vision (Siemens). To provide comparability, the
following pulse sequences were applied: in the Gyroscan, T1 (TR 700 ms,
TE 14 ms), T2 (TR 2200 ms, TE 80 ms), and PD (TR 2200 ms, TE 20 ms);
and in the Vision, T1 (TR 485 ms, TE 14 ms), T2 (TR 2236 ms, TE 90 ms),
and PD (TR 2236 ms, TE 20 ms). Slice thicknesses were 6 and 5 mm,
respectively, with an interslice gap of 20.0%. The images were printed
on hard copy with a reduction factor of 2.7.
White Matter Lesion Rating Scale
White matter lesions were considered present if they were
visible as hyperintense on both PD- and T2-weighted images and not
hypointense on T1-weighted images. White matter lesions were
distinguished into those in the deep subcortical and the
periventricular regions (Figure 1
). The number and size of deep
subcortical white matter lesions were rated on hard copy according to
their largest diameter in categories of small (<3 mm), medium (3
to 10 mm), or large (>10 mm) lesions. To calculate a deep
subcortical white matter lesion volume on hard copy, white matter
lesions were considered to be spherical, with a fixed diameter per size
category. Periventricular white matter lesions were rated
semiquantitatively per region: adjacent to frontal horn (frontal
capping), adjacent to lateral wall of lateral ventricles (bands), and
adjacent to occipital horn (occipital capping) on a scale ranging from
0 (no white matter lesions), to 1 (pencil-thin
periventricular lining), 2 (smooth halo or thick lining),
and 3 (large, confluent white matter lesions). The overall degree of
periventricular white matter lesions was calculated by
adding up the scores for the 3 separate categories (range, 0 to 9).
|
All MRI scans were examined by 2 raters from a pool of 4 experienced
raters. In case of a disagreement of >1 point, a consensus reading was
held; in all other cases, the readings of both readers were averaged.
The interrater and intrarater studies showed a good to excellent
agreement. Weighted
values for grading the
periventricular white matter lesions were between 0.79 and
0.90. For total deep subcortical white matter volume, the interreader
and intrarater intraclass correlation coefficients were 0.88 and 0.95,
respectively.
Statistical Analysis
The relation between aortic atherosclerosis and
white matter lesions was assessed by means of age- and sex-adjusted
logistic regression with the presence of severe white matter lesions as
the dependent variable. All analyses were also adjusted for
the following possible baseline confounding factors: body mass index,
total serum cholesterol, diabetes mellitus, hypertension,
and smoking (never, former, or current). The relative risk (RR), as
estimated by the odds ratio, was used to quantify the association.
White matter lesions were dichotomized at the upper quintile of their
distribution, reflecting the presence of severe white matter lesions.
Subjects without severe white matter lesions were the reference group
(lower 4 quintiles). The association between midlife and late-life
aortic atherosclerosis and presence of white matter
lesions was studied by entering aortic atherosclerosis
as a dichotomous variable (no versus mild or moderate to severe)
into the model. A possible dose-response relation between the severity
of aortic atherosclerosis and white matter lesions was
studied by creating dummy variables for the extent of aortic
atherosclerosis (none, mild, or moderate to severe).
The relative risks are presented with a 95% CI.
| Results |
|---|
|
|
|---|
|
Prevalence of aortic atherosclerosis was 21% at midlife and 59% at late life. During midlife, 218 subjects had no aortic atherosclerosis, whereas mild and moderate-to-severe aortic atherosclerosis was observed in 24 and 34 subjects, respectively. During late life, 219 subjects had no aortic atherosclerosis, whereas mild and moderate-to-severe aortic atherosclerosis was observed in 113 and 199 subjects, respectively. At follow-up, 20% of all participants were without any periventricular white matter lesions and 8% without subcortical white matter lesions.
Table 2
shows that the presence of aortic
atherosclerosis during midlife is significantly
associated with the presence of severe periventricular
white matter lesions 20 years later (RR, 2.4; 95% CI, 1.2 to 5.0) but
not with deep subcortical white matter lesions (RR, 1.1; 95% CI, 0.5
to 2.3). The risk for severe periventricular white matter
lesions 20 years later was 2.8 (95% CI, 1.0 to 7.0) for women (n=159)
and 2.4 (95% CI, 0.8 to 6.7) for men (n=117). The risk for severe
subcortical white matter lesions 20 years later was 1.1 (95% CI, 0.4
to 3.4) and 0.9 (95% CI, 0.3 to 2.7) for women and men, respectively.
In contrast, the presence of aortic atherosclerosis
during late life was not associated with either type of white matter
lesion.
|
Figure 2
shows a clear relation between
the extent of aortic atherosclerosis in midlife and the
presence of periventricular white matter lesions 20 years
later (Ptrend=0.002). There was no such
association with deep subcortical white matter lesions
(Ptrend=0.68). For mild and
moderate-to-severe aortic atherosclerosis in late life,
the relative risks of having periventricular white matter
lesions were 1.0 (95% CI, 0.5 to 1.9) and 0.7 (95% CI, 0.4 to 1.3),
and for deep subcortical white matter lesions, 1.2 (95% CI, 0.6 to
2.3) and 0.8 (95% CI, 0.4 to 1.4), respectively. Again, there were no
major sex differences in these associations.
|
| Discussion |
|---|
|
|
|---|
Some limitations and methodological issues need to be addressed. The overall response rate was 63%, and this may have led to selection bias, especially among the oldest participants. Still, we consider it unlikely that selection bias has played a major role in our study, because there were only small, nonsignificant, differences between participants and nonparticipants. We cannot exclude the possibility that our relative risks are somewhat underestimated, because we performed our study in survivors of the 2 baseline studies. Subjects who had died between baseline examination and follow-up may have had more severe aortic atherosclerosis than those who survived.
Another limitation is that no neuroimaging was available at baseline of the study. This makes it difficult to provide definitive proof of a temporal relation between aortic atherosclerosis and white matter lesions. As for the validity of radiographic assessment of aortic calcification for the diagnosis of atherosclerosis, an autopsy study showed that radiographically detected aortic calcification represented true intimal atherosclerosis.14 Compared with CT, it was shown that calcifications seen on the radiograph were in the vessel wall in all cases.22
The association between aortic atherosclerosis and cerebral white matter lesions was found only for aortic plaques in midlife and not for those found in late life. The explanation may be that subjects who already had mild or severe aortic atherosclerosis during midlife had progressed to more severe atherosclerosis at the time of the MRI scan than subjects with a similar degree of aortic atherosclerosis at a much higher age. Apparently, it takes many years before atherosclerosis progresses to such a severe stage that it is reflected in the brain. Our finding of a linear relation between severity of aortic atherosclerosis and the presence of white matter lesions supports this interpretation. Another explanation for the weak association between late-life aortic atherosclerosis and white matter lesions might be that in elderly subjects, the presence of atherosclerosis has less discriminative power, because many other risk factors for white matter lesions coexist.
The association between aortic atherosclerosis and white matter lesions was confined to periventricular white matter lesions. This suggests that different pathophysiological processes underlie periventricular and subcortical white matter lesions, possibly related to vascularization. Because the periventricular white matter is an arterial border zone, already marginally perfused under physiological circumstances, it is especially vulnerable to a decrease of cerebral blood flow.23 24 25 In contrast, the subcortical white matter is not an arterial watershed area.26 Atherosclerosis induces hyalinization, tortuosity, and elongation of vessels in the periventricular white matter.24 27 28 29 This may contribute to a decrease in blood flow in the periventricular white matter, leading to ischemia.24 This explanation is supported by studies that found an association between periventricular white matter lesions and atherosclerosis-related factors as hypertension, diabetes mellitus, and the presence of silent infarcts.30
In conclusion, our study shows that aortic atherosclerosis during midlife is a major risk factor for periventricular white matter lesions in the brain at greater age. Our results suggest that the presence of atherosclerosis at middle age is already predictive for the presence of white matter lesions later in life. Any therapeutic intervention should therefore preferably take place at the early stages of atherosclerosis.
| Acknowledgments |
|---|
Received August 9, 1999; revision received November 12, 1999; accepted November 12, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M van Oijen, E Y L Cheung, C E M Geluk, A Hofman, P J Koudstaal, M M B Breteler, and M P de Maat Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 799 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Libon, C. C. Price, T. Giovannetti, R. Swenson, B. M. Bettcher, K. M. Heilman, and A. Pennisi Linking MRI Hyperintensities With Patterns of Neuropsychological Impairment: Evidence for a Threshold Effect Stroke, March 1, 2008; 39(3): 806 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Debette, S. Bombois, A. Bruandet, X. Delbeuck, S. Lepoittevin, C. Delmaire, D. Leys, and F. Pasquier Subcortical Hyperintensities Are Associated With Cognitive Decline in Patients With Mild Cognitive Impairment Stroke, November 1, 2007; 38(11): 2924 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Spilt, R. Goekoop, R.G.J. Westendorp, G.J. Blauw, A.J.M. de Craen, and M.A. van Buchem Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study. AJNR Am. J. Neuroradiol., October 1, 2006; 27(9): 1964 - 1968. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Spilt, T. Geeraedts, A. J. M. de Craen, R. G. J. Westendorp, G. J. Blauw, and M. A. van Buchem Age-Related Changes in Normal-Appearing Brain Tissue and White Matter Hyperintensities: More of the Same or Something Else? AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 725 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. DeCarli, E. Fletcher, V. Ramey, D. Harvey, and W. J. Jagust Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden Stroke, January 1, 2005; 36(1): 50 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
F-E de Leeuw, F Barkhof, and P Scheltens Alzheimer's disease--one clinical syndrome, two radiological expressions: a study on blood pressure J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1270 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Kuo and L. A. Lipsitz Cerebral White Matter Changes and Geriatric Syndromes: Is There a Link? J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): M818 - M826. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Sijens, T. d. Heijer, D. Origgi, S. E. Vermeer, M. M. B. Breteler, A. Hofman, and M. Oudkerk Brain Changes with Aging: MR Spectroscopy at Supraventricular Plane Shows Differences between Women and Men Radiology, March 1, 2003; 226(3): 889 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-E. de Leeuw, J. C. de Groot, M. Oudkerk, J. C. M. Witteman, A. Hofman, J. van Gijn, and M. M. B. Breteler Hypertension and cerebral white matter lesions in a prospective cohort study Brain, March 1, 2002; 125(4): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Havlik, D. J. Foley, B. Sayer, K. Masaki, L. White, and L. J. Launer Variability in Midlife Systolic Blood Pressure Is Related to Late-Life Brain White Matter Lesions: The Honolulu-Asia Aging Study Stroke, January 1, 2002; 33(1): 26 - 30. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |